Practice Guideline
doi: 10.2450/2009.0116-09.
Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates
Affiliations
- PMID: 20011645
- PMCID: PMC2782811
- DOI: 10.2450/2009.0116-09
Item in Clipboard
Practice Guideline
Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates
Blood Transfus.
2009 Oct.
No abstract available
Similar articles
-
Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients.Intensive Care Med. 1999 Oct;25(10):1105-10. doi: 10.1007/s001340051019. Intensive Care Med. 1999. PMID: 10551966 Free PMC article. Clinical Trial.
-
Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate.Anesth Analg. 2017 Nov;125(5):1471-1474. doi: 10.1213/ANE.0000000000002410. Anesth Analg. 2017. PMID: 28857856 Free PMC article.
-
Use of prothrombin complex concentrates for urgent reversal of dabigatran in the Emergency Department.Haematologica. 2013 Nov;98(11):e143-4. doi: 10.3324/haematol.2013.092767. Haematologica. 2013. PMID: 24186317 Free PMC article. No abstract available.
-
Perioperative factor concentrate therapy.Br J Anaesth. 2013 Dec;111 Suppl 1:i35-49. doi: 10.1093/bja/aet380. Br J Anaesth. 2013. PMID: 24335398 Review.
-
Use of prothrombin complex concentrates for prophylaxis and treatment of bleeding episodes in patients with hereditary deficiency of prothrombin, factor VII, factor X, protein C protein S, or protein Z.Thromb Res. 1999 Aug 15;95(4 Suppl 1):S39-50. doi: 10.1016/s0049-3848(99)00083-3. Thromb Res. 1999. PMID: 10499908 Review. No abstract available.
Cited by
-
Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period.Blood Transfus. 2011 Apr;9(2):189-217. doi: 10.2450/2011.0075-10. Blood Transfus. 2011. PMID: 21527082 Free PMC article. No abstract available.
-
How we treat bleeding associated with direct oral anticoagulants.Blood Transfus. 2016 Sep;14(5):465-73. doi: 10.2450/2016.0180-15. Epub 2016 Jan 19. Blood Transfus. 2016. PMID: 27136433 Free PMC article. Review.
-
Antithrombin Therapy: Current State and Future Outlook.Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231205279. doi: 10.1177/10760296231205279. Clin Appl Thromb Hemost. 2023. PMID: 37822179 Free PMC article.
-
Exploring the pathways of inflammation and coagulopathy in COVID-19: A narrative tour into a viral rabbit hole.Int Rev Immunol. 2022;41(4):414-422. doi: 10.1080/08830185.2021.1993211. Epub 2021 Oct 22. Int Rev Immunol. 2022. PMID: 34678120 Free PMC article. Review.
-
The clinical use of albumin: a topic for Transfusion Medicine.Blood Transfus. 2009 Oct;7(4):249. doi: 10.2450/2009.0136-09. Blood Transfus. 2009. PMID: 20011635 Free PMC article. No abstract available.
References
-
- Hathaway WE, Goodnight SH., Jr . Malattie dell’Emostasi e Trombosi. Milan, Italy: McGraw-Hill Companies Italia; 1994.
-
- Blondel-Hill E, Mant MJ. The pregnant antithrombin III deficient patient: management without antithrombin III concentrate. Thromb Res. 1992;65:193–8. - PubMed
-
- Inthorn D, Hoffmann JN, Hartl WH, et al. Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis. Shock. 1998;2:90–6. - PubMed
-
- Prinoth O.Servizio Aziendale di Immunoematologia e Trasfusione - Comprensorio Sanitario di Bolzano. Terapia con emocomponenti e plasmaderivati: linee guida ed aspetti medico-legali January2007. Available at: http://www.asbz.it/portal/it/document/IT/direzione/LINEE%20GUIDA%20ALLA%...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
